[Recent controversy in treatment for advanced bladder cancer]

Gan To Kagaku Ryoho. 1998 Sep;25(11):1696-700.
[Article in Japanese]

Abstract

We summarized here the current status and controversy surrounding treatment for advanced bladder cancer, which may be defined as deeply invasive bladder cancer or invasive bladder cancer with distant metastasis. The definitive treatment for advanced bladder cancer is considered to be systemic chemotherapy. However, favorable results are not always obtained from CDDP-based combination chemotherapy alone. Therefore, the development of a dose-intensified regimen using G-CSF, intra-arterial chemotherapy, based on the concept of the drug delivery system, and combination therapy of radiation and chemotherapy, produced better results. Surgical treatment, a part of a multidisciplinary approach, may result in a complete response followed by a good prognosis.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Drug Delivery Systems
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • Humans
  • Methotrexate / administration & dosage
  • Urinary Bladder Neoplasms / radiotherapy
  • Urinary Bladder Neoplasms / therapy*
  • Vinblastine / administration & dosage

Substances

  • Granulocyte Colony-Stimulating Factor
  • Vinblastine
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin
  • Methotrexate

Supplementary concepts

  • CISCA protocol
  • M-VAC protocol